FFO
PFE icon

Fiduciary Family Office’s Pfizer PFE Stock Holding History

Fiduciary Family Office’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$667K Sell
27,679
-688
-2% -$18K 0.17% 96
2026
Q1 		$797K Buy
28,367
+17,270
+156% +$460K 0.23% 84
2025
Q4 		$276K Buy
11,097
+96
+0.9% +$2.42K 0.08% 149
2025
Q3 		$280K Sell
11,001
-6,369
-37% -$157K 0.08% 158
2025
Q2 		$421K Buy
17,370
+2,917
+20% +$68K 0.14% 129
2025
Q1 		$366K Buy
+14,453
New +$378K 0.12% 140
2024
Q4 		– Sell
-19,989
Closed -$578K – 201
2024
Q3 		$578K Buy
19,989
+833
+4% +$24.3K 0.19% 111
2024
Q2 		$536K Buy
19,156
+504
+3% +$13.9K 0.21% 123
2024
Q1 		$518K Buy
18,652
+3,225
+21% +$89.5K 0.2% 131
2023
Q4 		$444K Buy
+15,427
New +$466K 0.19% 131

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Fiduciary Family Office's PFE Position: Q2 2026 in Review

Fiduciary Family Office reduced its Pfizer (PFE) stake by 2.4% in Q2 2026, selling an estimated $18K and leaving 27,679 shares worth $667K. The position accounts for 0.17% of the portfolio, ranked #96.

Fiduciary Family Office first reported a position in PFE in Q4 2023 and has held it in 10 quarters since. The position peaked at $797K in Q1 2026. 2,831 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Fiduciary Family Office held 27,679 shares of Pfizer worth $667K as of Q2 2026.
  • Fiduciary Family Office sold 688 Pfizer shares in Q2 2026, an estimated $18K.
  • Pfizer made up 0.17% of Fiduciary Family Office's portfolio in Q2 2026, its #96 holding.
  • Fiduciary Family Office first reported a position in Pfizer in Q4 2023 and has held it in 10 quarters since.
  • Fiduciary Family Office's Pfizer position peaked at $797K in Q1 2026.
  • 2,831 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Fiduciary Family Office's 13F filing for Q2 2026, filed 5 Aug 2026.